Search Results 1411-1420 of 40193 for oral

1. Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution As Adjunctive Therapy In Children With Doose Syndrome - Mayo Clinic

   Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution As Adjunctive Therapy In Children With Doose Syndrome · Share · Facebook ...

2. Chlorpheniramine, ibuprofen, and pseudoephedrine (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For symptoms of allergies and cold: Adults and children 12 years of age and older—1 tablet every 4 to 6 hours a day. Do not ...

3. Vanzacaftor, tezacaftor, and deutivacaftor (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For cystic fibrosis: Adults and children 12 years of age and older—2 tablets (containing vanzacaftor 10 milligrams (mg) ...

4. Fedratinib (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (capsules):. For myelofibrosis: Adults—400 milligrams (mg) once a day, depending on your blood test results. Your doctor may adjust your ...

5. Medications and supplements that can raise your blood pressure - Mayo Clinic

   Some medicines and herbal remedies, including those used to treat pain, depression and the common cold, can increase blood pressure.

6. Black hairy tongue - Diagnosis and treatment - Mayo Clinic

   Foods or medicines that have stained the tongue. Fungal or viral infections. Patches that occur on the tongue, such as oral hairy leukoplakia. Blackened tongue, ...

7. Fosfomycin (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (powder for solution):. For treatment of bladder infection: Adults—3 grams (one packet) dissolved in water taken one time. Teenagers 13 ...

8. Alogliptin and pioglitazone (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For type 2 diabetes: Adults—Starting dose is based on the current alogliptin or pioglitazone you are already taking. Your ...

9. Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer

   A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...

10. The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

    The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) ...